
As part of the study, a total of 330 healthy volunteers who were not vaccinated and had no history of COVID infection were selected and screened for SARS-CoV-2 antibodies for the study.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eLetN7
via
IFTTT
0 comments:
Post a Comment